Adenocarcinoma of the esophagogastric junction: For perioperative chemotherapy, against neoadjuvant radiotherapy

被引：0
作者：
Lordick F. [1 ]
机构：
[1] Medizinische Klinik I (Hämatologie, Zelltherapie, Internistische Onkologie, Hämostaseologie), Universitäres Krebszentrum Leipzig (UCCL), Universitätsklinikum Leipzig, Liebigstr. 22, Leipzig
来源：
Der Onkologe | 2019年 / 25卷 / 12期
关键词：
Combined modality therapy; Esophageal cancer; Gastric cancer; Metastasis; Perioperative care;
D O I：
10.1007/s00761-019-0635-9
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1046 / 1049
页数：3
相关论文
共 50 条
  • [41] Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
    Springfeld, Christoph
    Wiecha, Christiane
    Kunzmann, Romy
    Heger, Ulrike
    Weichert, Wilko
    Langer, Rupert
    Stange, Annika
    Blank, Susanne
    Sisic, Leila
    Schmidt, Thomas
    Lordick, Florian
    Jaeger, Dirk
    Grenacher, Lars
    Bruckner, Tom
    Buechler, Markus W.
    Ott, Katja
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S905 - S914
  • [42] Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
    Christoph Springfeld
    Christiane Wiecha
    Romy Kunzmann
    Ulrike Heger
    Wilko Weichert
    Rupert Langer
    Annika Stange
    Susanne Blank
    Leila Sisic
    Thomas Schmidt
    Florian Lordick
    Dirk Jäger
    Lars Grenacher
    Tom Bruckner
    Markus W. Büchler
    Katja Ott
    Annals of Surgical Oncology, 2015, 22 : 905 - 914
  • [43] Predicting the depth of superficial adenocarcinoma of the esophagogastric junction
    Takada, Kazunori
    Yabuuchi, Yohei
    Yamamoto, Yoichi
    Yoshida, Masao
    Kawata, Noboru
    Takizawa, Kohei
    Kishida, Yoshihiro
    Ito, Sayo
    Imai, Kenichiro
    Hotta, Kinichi
    Ishiwatari, Hirotoshi
    Matsubayashi, Hiroyuki
    Kawabata, Takanori
    Ono, Hiroyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (02) : 363 - 370
  • [44] Adenocarcinoma of the esophagogastric junction-surgical technique
    Grimminger, Peter P.
    Lang, Hauke
    ONKOLOGE, 2019, 25 (12): : 1080 - 1085
  • [45] Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction
    Belmouhand, Mohamed
    Lofgren, Johan
    Johannesen, Helle Hjorth
    Baeksgaard, Lene
    Gutte, Henrik
    Tariq, Kiran
    Achiam, Michael Patrick
    ABDOMINAL RADIOLOGY, 2019, 44 (03) : 836 - 844
  • [46] Is There a Role For PET/CT With Esophagogastric Junction Adenocarcinoma?
    Fuster, David
    Mayoral, Maria
    Rubello, Domenico
    Pineda, Estela
    Fernandez-Esparrach, Gloria
    Pages, Mario
    Colletti, Patrick M.
    Pons, Francesca
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : E201 - E207
  • [47] Assessment of Diffusion-Weighted MRI and 18F-FluoroDeoxyglucose PET/CT in Monitoring Early Response to Neoadjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction
    Weber, Marc-Andre
    Bender, Karen
    von Gall, Carl Christian
    Stange, Annika
    Gruenberg, Katharina
    Ott, Katja
    Haberkorn, Uwe
    Kauczor, Hans-Ulrich
    Zechmann, Christian
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2013, 22 (01) : 45 - 52
  • [48] Prognostic Value of Intraoperative Blood Transfusion in Patients with Adenocarcinoma of the Esophagogastric Junction
    Nakajima, Kei
    Tokunaga, Masanori
    Okuno, Keisuke
    Saito, Katsumasa
    Fujiwara, Naoto
    Sato, Yuya
    Hoshino, Akihiro
    Matsuyama, Takatoshi
    Kinugasa, Yusuke
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [49] Differential Pathologic Variables and Outcomes across the Spectrum of Adenocarcinoma of the Esophagogastric Junction
    Reynolds, John V.
    Ravi, Narayanasamy
    Muldoon, Cian
    Larkin, John O.
    Rowley, Suzanne
    O'Byrne, Ken
    Hollywood, Donal
    O'Toole, Dermot
    WORLD JOURNAL OF SURGERY, 2010, 34 (12) : 2821 - 2829
  • [50] Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy
    Tian, Sibo
    Jiang, Renjian
    Madden, Nicholas A.
    Ferris, Matthew J.
    Buchwald, Zachary S.
    Xu, Karen M.
    Cardona, Kenneth
    Maithel, Shishir K.
    McDonald, Mark W.
    Lin, Jolinta Y.
    Curran, Walter J.
    El-Rayes, Bassel F.
    Behera, Madhusmita
    Patel, Pretesh R.
    CANCER, 2020, 126 (01) : 37 - 45
12345